JOHN R. MURPHY - 31 Dec 2024 SCHEDULE 13G/A Report for Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share (CVKD)

Filing Manager: JOHN R. MURPHY
Reporting Manager: John Raymond Murphy
Security: Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: CVKD
Shares outstanding: 1,797,466 shares
Disclosed Ownership: 53,205 shares
Ownership: 3%
Form type: SCHEDULE 13G/A
Filing time: 15 Jan 2025, 16:23:48 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
John Raymond Murphy	3%	53,205	53,205	0	/s/ John Raymond Murphy	John Raymond Murphy